Voya Investment Management LLC Oncocyte Corp Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $23,997 - $42,693	-27,904 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $9,072 - $17,750	7,889 Added 39.42%	27,904 $42,000
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $13,653 - $24,027	-6,693 Reduced 25.06%	20,015 $43,000
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $12,436 - $20,750	-3,523 Reduced 11.65%	26,708 $95,000
Q1 2021 May 17, 2021	SELL	$2.39 - $6.5 $74 - $201	-31 Reduced 0.1%	30,231 $157,000
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $13,822 - $26,342	10,016 Added 49.47%	30,262 $72,000
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $5,830 - $9,183	4,859 Added 31.58%	20,246 $28,000
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $29,389 - $53,085	15,387 New	15,387 $29,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.